{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:43:30Z","timestamp":1792410210771,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejca.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T08:15:44Z","timestamp":1474013744000},"page":"106-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes"],"prefix":"10.1016","volume":"67","author":[{"given":"G.","family":"Houvenaeghel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Boher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Reyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Garbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Classe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rouzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Giard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Charitansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tunon de Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Azuar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gimbergues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Villet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sfumato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lambaudie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejca.2016.08.003_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2016.08.003_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ejca.2016.08.003_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2016.08.003_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2016.08.003_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1684\/bdc.2014.1916","article-title":"[Sentinel node invasion: is it necessary to perform axillary lymph node dissection? Randomized trial SERC]","volume":"101","author":"Houvenaeghel","year":"2014","journal-title":"Bull Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2016.08.003_bib6","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1200\/JCO.2005.03.3225","article-title":"Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement\u2013Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer","volume":"24","author":"Houvenaeghel","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.08.003_bib7","series-title":"Statistics for biology and health: survival analysis, techniques for censored and truncated data","doi-asserted-by":"crossref","DOI":"10.1007\/b97377","author":"Klein","year":"2003"},{"issue":"7","key":"10.1016\/j.ejca.2016.08.003_bib8","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1200\/JCO.1996.14.7.1982","volume":"14","author":"Fisher","year":"1996","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2016.08.003_bib9","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1200\/JCO.2009.23.7610","article-title":"Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20","volume":"28","author":"Mamounas","year":"2010","journal-title":"J Clin Oncol"},{"issue":"33","key":"10.1016\/j.ejca.2016.08.003_bib10","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1200\/JCO.2014.55.5730","article-title":"Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831","volume":"32","author":"Perez","year":"2014","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2016.08.003_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2016.08.003_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2008.21.7554","article-title":"Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer","volume":"28","author":"Straver","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2016.08.003_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jso.23188","article-title":"The positive non-sentinel status is not the main decisional factor for chemotherapy assignment in breast cancer with micrometastatic disease in the sentinel lymph node","volume":"106","author":"Mazouni","year":"2012","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2016.08.003_bib14","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1245\/s10434-012-2798-0","article-title":"Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations","volume":"20","author":"Aigner","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2016.08.003_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clbc.2013.04.004","article-title":"Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?","volume":"13","author":"S\u00e1volt","year":"2013","journal-title":"Clin Breast Cancer"},{"issue":"34","key":"10.1016\/j.ejca.2016.08.003_bib16","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1200\/JCO.2011.36.1667","article-title":"Positive sentinel nodes without axillary dissection: implications for the radiation oncologist","volume":"29","author":"Haffty","year":"2011","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.ejca.2016.08.003_bib17","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2016.08.003_bib18","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/annonc\/mdt151","article-title":"The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I-II and the sentinel node area","volume":"24","author":"Belkacemi","year":"2013","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2016.08.003_bib19","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1245\/s10434-014-3966-1","article-title":"Breast radiotherapy (RT) using tangential fields (TgF): a prospective evaluation of the dose distribution in the sentinel lymph node (SLN) area as determined intraoperatively by clip placement","volume":"21","author":"Belkacemi","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"10.1016\/j.ejca.2016.08.003_bib20","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ejca.2008.06.033","article-title":"Variations in sentinel node isolated tumour cells\/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions","volume":"44","author":"Cserni","year":"2008","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2016.08.003_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1245\/s10434-011-1882-1","article-title":"A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement","volume":"19","author":"Meretoja","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2016.08.003_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejso.2014.01.014","article-title":"Cross-validation of three predictive tools for non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node","volume":"40","author":"Tvedskov","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"24","key":"10.1016\/j.ejca.2016.08.003_bib23","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/jnci\/djs455","article-title":"International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer","volume":"104","author":"Meretoja","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.ejca.2016.08.003_bib24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejso.2008.10.003","article-title":"A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis","volume":"35","author":"Houvenaeghel","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2016.08.003_bib25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.breast.2011.09.013","article-title":"Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models","volume":"21","author":"Houvenaeghel","year":"2012","journal-title":"Breast"},{"issue":"10","key":"10.1016\/j.ejca.2016.08.003_bib26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bjs.4725","article-title":"Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer","volume":"91","author":"Cserni","year":"2004","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ejca.2016.08.003_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.sla.0000150255.30665.52","article-title":"Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy","volume":"241","author":"Viale","year":"2005","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.ejca.2016.08.003_bib28","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/ijc.27499","article-title":"High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node","volume":"131","author":"Tvedskov","year":"2012","journal-title":"Int J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916323644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916323644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:27:00Z","timestamp":1601072820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804916323644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":28,"alternative-id":["S0959804916323644"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.08.003","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}